Albert Galera‐Prat

879 total citations
36 papers, 586 citations indexed

About

Albert Galera‐Prat is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Albert Galera‐Prat has authored 36 papers receiving a total of 586 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 15 papers in Oncology and 10 papers in Immunology. Recurrent topics in Albert Galera‐Prat's work include PARP inhibition in cancer therapy (13 papers), Toxin Mechanisms and Immunotoxins (10 papers) and Force Microscopy Techniques and Applications (6 papers). Albert Galera‐Prat is often cited by papers focused on PARP inhibition in cancer therapy (13 papers), Toxin Mechanisms and Immunotoxins (10 papers) and Force Microscopy Techniques and Applications (6 papers). Albert Galera‐Prat collaborates with scholars based in Finland, Spain and United States. Albert Galera‐Prat's co-authors include Mariano Carrión‐Vázquez, L. Lehtiö, Mirko M. Maksimainen, Marek Cieplak, Sven T. Sowa, Douglas V. Laurents, Ezeogo Obaji, Rubén Hervás, Marta Bruix and Andrés F. Oberhauser and has published in prestigious journals such as Advanced Materials, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Albert Galera‐Prat

36 papers receiving 584 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Albert Galera‐Prat Finland 14 366 160 88 88 71 36 586
Bettina van Lengerich United States 10 656 1.8× 80 0.5× 18 0.2× 101 1.1× 89 1.3× 12 843
David Ackerman United States 11 369 1.0× 31 0.2× 107 1.2× 37 0.4× 87 1.2× 13 667
Kersti Alm Sweden 14 297 0.8× 58 0.4× 96 1.1× 23 0.3× 76 1.1× 33 528
Nathalie George Switzerland 7 545 1.5× 39 0.2× 21 0.2× 92 1.0× 56 0.8× 8 777
Rubén Hervás Spain 13 493 1.3× 26 0.2× 115 1.3× 48 0.5× 27 0.4× 24 651
Ágnes Csiszár Germany 16 612 1.7× 29 0.2× 53 0.6× 81 0.9× 160 2.3× 38 914
Nathan H. Joh United States 11 662 1.8× 27 0.2× 36 0.4× 36 0.4× 80 1.1× 12 791
Alberto Mazzini Italy 17 373 1.0× 31 0.2× 28 0.3× 26 0.3× 83 1.2× 40 621
Sophia C. Goodchild Australia 14 528 1.4× 27 0.2× 30 0.3× 36 0.4× 27 0.4× 23 706
Anthony R. Braun United States 16 603 1.6× 20 0.1× 146 1.7× 48 0.5× 58 0.8× 27 877

Countries citing papers authored by Albert Galera‐Prat

Since Specialization
Citations

This map shows the geographic impact of Albert Galera‐Prat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert Galera‐Prat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert Galera‐Prat more than expected).

Fields of papers citing papers by Albert Galera‐Prat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Albert Galera‐Prat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert Galera‐Prat. The network helps show where Albert Galera‐Prat may publish in the future.

Co-authorship network of co-authors of Albert Galera‐Prat

This figure shows the co-authorship network connecting the top 25 collaborators of Albert Galera‐Prat. A scholar is included among the top collaborators of Albert Galera‐Prat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Albert Galera‐Prat. Albert Galera‐Prat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sowa, Sven T., Albert Galera‐Prat, Dana Ferraris, et al.. (2024). Discovery of 2-Amide-3-methylester Thiophenes that Target SARS-CoV-2 Mac1 and Repress Coronavirus Replication, Validating Mac1 as an Antiviral Target. Journal of Medicinal Chemistry. 67(8). 6519–6536. 6 indexed citations
2.
Maksimainen, Mirko M., Serena Massari, Barbara E. Lippok, et al.. (2023). [1,2,4]Triazolo[3,4- b ]benzothiazole Scaffold as Versatile Nicotinamide Mimic Allowing Nanomolar Inhibition of Different PARP Enzymes. Journal of Medicinal Chemistry. 66(2). 1301–1320. 15 indexed citations
3.
Maksimainen, Mirko M., Serena Massari, Barbara E. Lippok, et al.. (2022). Potent 2,3-dihydrophthalazine-1,4-dione derivatives as dual inhibitors for mono-ADP-ribosyltransferases PARP10 and PARP15. European Journal of Medicinal Chemistry. 237. 114362–114362. 7 indexed citations
4.
Sowa, Sven T., et al.. (2022). An Evolutionary Perspective on the Origin, Conservation and Binding Partner Acquisition of Tankyrases. Biomolecules. 12(11). 1688–1688. 4 indexed citations
5.
Galera‐Prat, Albert, et al.. (2022). Protein engineering approach to enhance activity assays of mono-ADP-ribosyltransferases through proximity. Protein Engineering Design and Selection. 35. 5 indexed citations
6.
Espada, Sandra, Clara Hammarström, Aleksandra Aizenshtadt, et al.. (2022). The Tankyrase Inhibitor OM-153 Demonstrates Antitumor Efficacy and a Therapeutic Window in Mouse Models. Cancer Research Communications. 2(4). 233–245. 11 indexed citations
7.
Sowa, Sven T., et al.. (2021). A molecular toolbox for ADP-ribosyl binding proteins. Cell Reports Methods. 1(8). 100121–100121. 25 indexed citations
8.
Obaji, Ezeogo, Mirko M. Maksimainen, Albert Galera‐Prat, & L. Lehtiö. (2021). Activation of PARP2/ARTD2 by DNA damage induces conformational changes relieving enzyme autoinhibition. Nature Communications. 12(1). 3479–3479. 48 indexed citations
9.
Korn, Patricia, Arno Claßen, Mirko M. Maksimainen, et al.. (2021). Evaluation of 3‐ and 4‐Phenoxybenzamides as Selective Inhibitors of the Mono‐ADP‐Ribosyltransferase PARP10. ChemistryOpen. 10(10). 939–948. 10 indexed citations
10.
Hervás, Rubén, Albert Galera‐Prat, Mari Suzuki, et al.. (2021). Divergent CPEB prion-like domains reveal different assembly mechanisms for a generic amyloid-like fold. BMC Biology. 19(1). 43–43. 16 indexed citations
11.
Leenders, Ruben G.G., Sven T. Sowa, Albert Galera‐Prat, et al.. (2021). Development of a 1,2,4-Triazole-Based Lead Tankyrase Inhibitor: Part II. Journal of Medicinal Chemistry. 64(24). 17936–17949. 16 indexed citations
12.
Vera, Andrés Manuel, Albert Galera‐Prat, Bartosz Różycki, et al.. (2021). Cohesin-dockerin code in cellulosomal dual binding modes and its allosteric regulation by proline isomerization. Structure. 29(6). 587–597.e8. 13 indexed citations
13.
Maksimainen, Mirko M., et al.. (2020). Activity-Based Screening Assay for Mono-ADP-Ribosylhydrolases. SLAS DISCOVERY. 26(1). 67–76. 13 indexed citations
14.
Waaler, Jo, Ruben G.G. Leenders, Sven T. Sowa, et al.. (2020). Preclinical Lead Optimization of a 1,2,4-Triazole Based Tankyrase Inhibitor. Journal of Medicinal Chemistry. 63(13). 6834–6846. 24 indexed citations
15.
Sowa, Sven T., et al.. (2020). A FRET-based high-throughput screening platform for the discovery of chemical probes targeting the scaffolding functions of human tankyrases. Scientific Reports. 10(1). 12357–12357. 23 indexed citations
16.
Oroz, Javier, et al.. (2019). Nanomechanics of tip-link cadherins. Scientific Reports. 9(1). 13306–13306. 8 indexed citations
17.
Galera‐Prat, Albert, Nadeem Joudeh, Miguel Alcalde, et al.. (2019). Resurrection of efficient Precambrian endoglucanases for lignocellulosic biomass hydrolysis. Communications Chemistry. 2(1). 28 indexed citations
18.
Hervás, Rubén, et al.. (2018). Efficient and simplified nanomechanical analysis of intrinsically disordered proteins. Nanoscale. 10(35). 16857–16867. 5 indexed citations
19.
Hervás, Rubén, Javier Oroz, Albert Galera‐Prat, et al.. (2012). Common Features at the Start of the Neurodegeneration Cascade. PLoS Biology. 10(5). e1001335–e1001335. 52 indexed citations
20.
Galera‐Prat, Albert, et al.. (2010). Understanding biology by stretching proteins: recent progress. Current Opinion in Structural Biology. 20(1). 63–69. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bettina van Lengerich Breakdown of academic impact, for papers by David Ackerman Breakdown of academic impact, for papers by Kersti Alm Breakdown of academic impact, for papers by Nathalie George Breakdown of academic impact, for papers by Rubén Hervás Breakdown of academic impact, for papers by Ágnes Csiszár Breakdown of academic impact, for papers by Nathan H. Joh Breakdown of academic impact, for papers by Alberto Mazzini Breakdown of academic impact, for papers by Sophia C. Goodchild Breakdown of academic impact, for papers by Anthony R. Braun
Rankless by CCL
2026